| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 10/03/2001 | CA2343488A1 Test methods and devices |
| 10/03/2001 | CA2342677A1 Methods and compositions for screening icrac modulators |
| 10/02/2001 | US6297429 Gene for transcription factor capable of altering characters of a plant and use thereof |
| 10/02/2001 | US6297369 Nucleotide sequence coding insect pesticide; for use in biological pest control |
| 10/02/2001 | US6297364 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 10/02/2001 | US6297361 Use of histidine decarboxylase immunoreactivity to detect human cancer |
| 10/02/2001 | US6297359 Polypeptide for use in the treatment of diabetes, dietetics, hypertension and premature atherosclerosis |
| 10/02/2001 | US6297221 Method for promoting angiogenesis with a nucleic acid construct comprising an SM22α0 promoter |
| 10/02/2001 | US6297220 Recombinant adenovirus comprising a dna sequence that codes for a gene product is delivered to a cardiac or vascular smooth muscle cell and the cell is maintained until that gene product is expressed. |
| 10/02/2001 | US6297213 Osteogenic devices |
| 10/02/2001 | US6297054 Editing-based selectable plastid marker genes |
| 10/02/2001 | US6297052 Cell culture; for use in proliferation of preferential compounds in cells |
| 10/02/2001 | US6297051 Suppression of tumor propagation; incubate cells with preferential suppression oligopeptides and monitor sample for adjusted tumor activity |
| 10/02/2001 | US6297050 Activation of t-cell response; mix peptides with sample containing t-cells and detect bound human leukocyte antigens |
| 10/02/2001 | US6297039 Amps from Streptococcus pneumoniae |
| 10/02/2001 | US6297037 Oxidatively stable alpha-amylase |
| 10/02/2001 | US6297036 YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 10/02/2001 | US6297029 Mammalian artificial chromosomes |
| 10/02/2001 | US6297028 IL-2R-associated polypeptide and DNA molecules coding therefor |
| 10/02/2001 | US6297012 Cytoplasmic male sterility DNA factor and utilization thereof |
| 10/02/2001 | US6297003 Methods for the detection of a novel hepatitis C virus (HCV) terminal 3′ noncoding region |
| 10/02/2001 | US6296851 For screening antibiotics |
| 10/02/2001 | US6296844 Administering asialointerferon-.beta.. to mammal for therapy of viral hepatitis |
| 10/02/2001 | CA2234715C Method for inhibiting chymopapain and papain enzyme activity with polysaccharides of animal origin |
| 10/02/2001 | CA1341299C Mammalian interleukin-4 |
| 09/30/2001 | CA2310365A1 Passive and active protection against mycobacterial infections |
| 09/30/2001 | CA2303550A1 A process for the production of stable (+) catechin penta acetate useful as a precursor for the production of (+) catechin |
| 09/27/2001 | WO2001071309A2 Methods and reagents for regulation of cellular responses in biological systems |
| 09/27/2001 | WO2001071046A1 Suppressor of hiv replication and transcription |
| 09/27/2001 | WO2001071027A2 mRNA AMPLIFICATION |
| 09/27/2001 | WO2001071018A2 Secreting products from skin by adeno-associated virus (aav) gene transfer |
| 09/27/2001 | WO2001071016A1 Pluripotential stem cells |
| 09/27/2001 | WO2001071007A2 GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF |
| 09/27/2001 | WO2001071005A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 09/27/2001 | WO2001071004A2 Proteases |
| 09/27/2001 | WO2001070991A1 Vaccine against mycobacterium infection based on epitopes of ag85 complex |
| 09/27/2001 | WO2001070989A2 Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
| 09/27/2001 | WO2001070984A2 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 09/27/2001 | WO2001070978A2 Polypeptides and nucleic acids encoding same |
| 09/27/2001 | WO2001070977A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 09/27/2001 | WO2001070975A1 Novel melanin concentrating hormone receptor |
| 09/27/2001 | WO2001070968A2 Production of recombinant blood clotting factors in human cell lines |
| 09/27/2001 | WO2001070952A1 Human gata-5 transcription factor |
| 09/27/2001 | WO2001070949A1 Genetic silencing |
| 09/27/2001 | WO2001070945A1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments |
| 09/27/2001 | WO2001070941A2 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 09/27/2001 | WO2001070940A1 Genetic constructs for regulated expression of insulin |
| 09/27/2001 | WO2001070939A1 Methods for transforming plant plastids and making transplastomic plants |
| 09/27/2001 | WO2001070938A1 Detection of immunological memory, t-cell conjugates for pathology imaging and therapy |
| 09/27/2001 | WO2001070816A2 Ecdysone receptor-based inducible gene expression system |
| 09/27/2001 | WO2001070811A1 Potassium channel protein kcnq5, a target for diseases of central nervous system and cardiovascular system |
| 09/27/2001 | WO2001070808A2 Angiogenesis - associated proteins, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070807A2 G-protein associated molecules |
| 09/27/2001 | WO2001070804A1 7 human ovarian and ovarian cancer associated proteins |
| 09/27/2001 | WO2001070799A1 Novel protein having hemolytic activity and gene encoding the protein |
| 09/27/2001 | WO2001070798A2 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 09/27/2001 | WO2001070797A1 Ligand-controlled anion channels of insects |
| 09/27/2001 | WO2001070777A2 Leafy cotyledon2 genes and their uses |
| 09/27/2001 | WO2001070775A2 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 09/27/2001 | WO2001070771A2 Acute neuronal induced calcium binding protein type 1 ligand |
| 09/27/2001 | WO2001070767A2 Therapeutic anti-melanoma compounds |
| 09/27/2001 | WO2001070766A2 Therapeutic anti-cytomegalovirus compounds |
| 09/27/2001 | WO2001070261A1 Sperm factor oscillogenin |
| 09/27/2001 | WO2001070175A2 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 09/27/2001 | WO2001070174A2 Vegf-modulated genes and methods employing them |
| 09/27/2001 | WO2001070015A1 Methods for gamete production in birds |
| 09/27/2001 | WO2001032126A3 Congenic animal models of non-insulin dependent diabetes mellitus |
| 09/27/2001 | WO2001030754A3 Micro-cluster liquids and methods of making and using them |
| 09/27/2001 | WO2001020013A3 Viral replicons and viruses dependent on inducing agents |
| 09/27/2001 | WO2001019992A3 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIV ES |
| 09/27/2001 | WO2001019975A3 Plants having reduced activity in two or more starch-modifying enzymes |
| 09/27/2001 | WO2001019973A3 Nicotinic acetylcholine receptor: alpha10 subunit |
| 09/27/2001 | WO2001018232A3 Drug target isogenes: polymorphisms in the uncoupling protein 3 (mitochondrial, proton carrier) gene |
| 09/27/2001 | WO2001018174A3 Cell growth substrate |
| 09/27/2001 | WO2001016296A3 Use of cytokines, cells, and mitogens to inhibit graft versus host disease |
| 09/27/2001 | WO2001016176A3 Transgenic animal model for neurodegenerative diseases |
| 09/27/2001 | WO2001016170A3 Card proteins involved in cell death regulation |
| 09/27/2001 | WO2001014539A3 Methods and compositions for the construction and use of fusion libraries |
| 09/27/2001 | WO2001014533A3 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 09/27/2001 | WO2001012127B1 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 09/27/2001 | WO2001010903A3 Proteases and protease inhibitors |
| 09/27/2001 | WO2001009178A3 Human chaperone proteins |
| 09/27/2001 | WO2001002430A3 Arabidopsis thaliana cdc7 and cdc27 homologs |
| 09/27/2001 | WO2000071148A3 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin |
| 09/27/2001 | WO2000046386A9 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site |
| 09/27/2001 | US20010025026 Chimeric proteins for use in transport of a selected substance into cells |
| 09/27/2001 | US20010024827 Which express a neuron-specific marker and which can give rise to progeny which can differentiate into neuronal cells; for treatment of neuronal disorders |
| 09/27/2001 | US20010024826 Method of preparing an undifferentiated cell |
| 09/27/2001 | US20010024825 Capable of proliferation in in vitro culture for one year, maintains karyotype in which all chromosomes characteristic of human species are present, has potential to differentiate to derivatives of endoderm, mesoderm and ectoderm tissues |
| 09/27/2001 | US20010024824 Stem cells and their use in transplantation |
| 09/27/2001 | US20010024822 Culturing human cells with the use of a culture device having an affinity for protein |
| 09/27/2001 | US20010024817 Viral nucleotide sequences |
| 09/27/2001 | US20010024813 Human dendriac and brainiac-3 |
| 09/27/2001 | US20010024809 Administering phenylpropanoid derivative as nutrient or therapy; cultured from Ajuga plant under aerobic conditions; free radical scavengers |
| 09/27/2001 | US20010024807 Polynucleotides encoding crippled selectable marker such as neomycin resistance; heterologous polypeptides of interest; amplifiable selectable marker such as dehydrofolate reductase |
| 09/27/2001 | US20010024801 Viable, biologically pure exfoliated fecal colonocytes isolated at normal ambient temperature |
| 09/27/2001 | US20010024650 Artery - and vein-specific proteins and uses therefor |
| 09/27/2001 | US20010024648 Four monkey monoclonal antibodies 7B6, 16C10, 7C10 and 20C9 which inhibit the B7:CD28 pathway and thereby function as effeftive immunosuppressants for the treatment of autoimmune diseases and prevent organ trasplant rejection |
| 09/27/2001 | DE10013732A1 New DNA sequence encoding potassium channel KCNQ5, useful in screening for specific modulators, potential agents for treating central nervous system and cardiovascular diseases |
| 09/27/2001 | CA2406993A1 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |